Pharmacist education on oral cancer drugs
Part of Cancer clinical trials.
This study tests whether an educational program helps community pharmacists in Malaysia better support patients taking oral cancer medicines. If you are a pharmacist, you may join to learn more about these drugs and improve your counseling skills.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a registered pharmacist working in a community pharmacy in Malaysia.
- You can read and understand English.
- You have basic computer or tablet skills (like using email or filling out online forms).
- You are willing to complete all surveys and possibly take part in an interview.
- You have not been part of a previous review of this type of educational program.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well patients with neuroendocrine tumors handle oral cancer pills and how those pills affect their quality of life. The goal is to improve support and education for people taking these medications at home.
This study tests a set of practical support steps to help people with advanced cancer take their oral (by mouth) treatment medicines correctly. It may help improve adherence and reduce missed doses or appointments.
This trial is testing whether a clinical pharmacist can help people with cancer who take oral medications at home. If you have a solid tumor cancer (not a blood cancer) and are starting a new oral treatment, you may be able to join.
This trial studies whether a team-based clinic visit program can improve how well people stick to their oral (by mouth) cancer medicines. It may help by offering extra support at the start of treatment or after a cancer comes back.
This study tests whether a pharmacist helping you organize and understand your cancer medications can improve your care. You'll work with a pharmacist at the clinic to review your medicines and learn how to take them safely.
This study follows patients who take oral anticancer drugs and take part in a special monitoring program at Lyon-Sud hospital. It aims to understand what affects treatment safety and outcomes.
Hear when a new Oral Anti-Tumor Drugs trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.